Skip to main contentSkip to navigationSkip to navigation
Bruce Springsteen in New York in 2016. Springsteen on Broadway is being seen as a test for a wider Broadway reopening.
Bruce Springsteen in New York in 2016. Springsteen on Broadway is being seen as a test for a wider Broadway reopening. Photograph: Greg Allen/Invision/AP
Bruce Springsteen in New York in 2016. Springsteen on Broadway is being seen as a test for a wider Broadway reopening. Photograph: Greg Allen/Invision/AP

Springsteen’s back on Broadway – and now AstraZeneca vaccine recipients are allowed

This article is more than 2 years old

Ban lifted after fans at first told only those with US-approved Covid vaccines could see singer’s return

Bruce Springsteen is bringing glory days back to New York next week, when his show becomes the first to reopen on Broadway since the lights went out for the coronavirus pandemic. But it looked initially as though fans without vaccinations approved by the US government would be left dancing in the dark.

The Boss was reported to have laid down strict rules for attendees of Springsteen on Broadway, which reopens on 26 June at the St James theatre. For admission, ticketholders would have had to prove they had received one of the three Covid-19 vaccinations with emergency use authorisation from the US Food and Drug Administration: the two-dose Pfizer-BioNTech or Moderna vaccines, or the single-shot Johnson & Johnson.

This ruled out attendance – at what the show’s producers are billing as “an intimate night with Bruce, his guitar, a piano and his stories” – by those with doses of the AstraZeneca-Oxford jab, which is not approved for use in the US but is popular in Canada, the UK and other countries.

The theatre’s owners, Jujamcyn, said it imposed the stipulation “at the direction of New York state”, and that the only exception would be for children 16 or younger, who must still produce proof of a recent negative Covid-19 test and be accompanied by a fully-vaccinated adult.

Understandably, the news was not well received in Canada, where the Toronto Star published a report on the perceived snub with the headline Burn in the USA, a play on the title of one of the 71-year-old Springsteen’s bestselling hits.

“The show must go on. But if you got the AstraZeneca vaccine, you’re not invited,” the newspaper wrote.

Jujamcyn evidently reconsidered. It announced it was reversing its decision and, based on updated guidance from state health officials, would be admitting ticket holders “who are fully vaccinated with an FDA or WHO approved vaccine”. The World Health Organization has approved the AstraZeneca-Oxford vaccine.

Mask-wearing is not required, and producers point out that seating inside the 1,710-capacity theatre is not socially distant.

Springsteen on Broadway is being seen as a test for a wider Broadway reopening, with many other shows not planning their own curtains-up until September or later.

The singer expressed his frustration at not being able to perform because of the pandemic in an interview with the New York Times last year. “My band is at its best, and we have so much accumulated knowledge and craft about what we do that this was a time in my life where I said, ‘I want to use that as much as I can’,” he said.

“I’m at a point in my playing life and artistic life where I’ve never felt as vital.”

AstraZeneca has had a bumpy ride attempting to get its vaccine approved in the US. The company claims the immunisation is 76% effective in preventing symptomatic Covid-19, 85% effective in those over 65, and 100% effective against severe disease and hospitalisation.

Despite the vaccine’s approval in Canada, the UK and Europe, the FDA has demanded evidence from larger-scale trials, results of which the company announced in March.

The Wall Street Journal reported last month that the company was considering forgoing an application for emergency use authorisation in the US and skipping straight to seeking full approval.

This article was updated on 21 June 2021 to include Jujamcyn’s acceptance of concert-goers with the AstraZeneca-Oxford vaccine, a change that came after initial publication of this article.

Most viewed

Most viewed